| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |